Matches in SemOpenAlex for { <https://semopenalex.org/work/W2169239924> ?p ?o ?g. }
Showing items 1 to 80 of
80
with 100 items per page.
- W2169239924 endingPage "745" @default.
- W2169239924 startingPage "742" @default.
- W2169239924 abstract "Summary A double-blind, randomized, cross-over, placebo-controlled study was carried out to determine the extent and duration of potentiation of the action of bradykinin introduced intradermally by a long-acting novel angiotensin converting enzyme (ACE) inhibitor, trandolapril. The investigations were performed in a temperature and humidity-controlled laboratory. Intradermal injections of 1 microgram, 2.5 micrograms and 5 micrograms of bradykinin and normal saline (as control) were made into the forearm skin of eight healthy normotensive male volunteers aged 21-33 years (mean 28 years) at baseline, 2, 4, 8, 24, 48, 72 and 96 hours after either 2 mg trandolapril or placebo given orally. Skin blood flow outside the induced weal was monitored by laser Doppler flowmetry (mean of recordings at four sites adjacent to the weal within the flare area). Flare area and weal volume were also measured. Trandolapril reduced the mean arterial pressure. However, there was no evidence that this activity was associated with a potentiation of the cutaneous action of bradykinin. In conclusion, it would appear that potentiation of the action of bradykinin may not be an important contributing factor to the fall in total peripheral vascular resistance associated with ACE inhibition in humans in the control of hypertension." @default.
- W2169239924 created "2016-06-24" @default.
- W2169239924 creator A5009003309 @default.
- W2169239924 creator A5012013682 @default.
- W2169239924 creator A5016163078 @default.
- W2169239924 creator A5070219180 @default.
- W2169239924 date "1992-09-01" @default.
- W2169239924 modified "2023-09-27" @default.
- W2169239924 title "Absence of potentiation of the skin response to intradermal bradykinin by a long-acting angiotensin converting enzyme inhibitor, trandolapril, at conventional antihypertensive dosage in human volunteers: a double-blind, randomized, cross-over, placebo-controlled trial" @default.
- W2169239924 cites W2019205604 @default.
- W2169239924 cites W2028067695 @default.
- W2169239924 cites W2030365219 @default.
- W2169239924 cites W2053223956 @default.
- W2169239924 doi "https://doi.org/10.1136/pgmj.68.803.742" @default.
- W2169239924 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2399455" @default.
- W2169239924 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/1480537" @default.
- W2169239924 hasPublicationYear "1992" @default.
- W2169239924 type Work @default.
- W2169239924 sameAs 2169239924 @default.
- W2169239924 citedByCount "1" @default.
- W2169239924 crossrefType "journal-article" @default.
- W2169239924 hasAuthorship W2169239924A5009003309 @default.
- W2169239924 hasAuthorship W2169239924A5012013682 @default.
- W2169239924 hasAuthorship W2169239924A5016163078 @default.
- W2169239924 hasAuthorship W2169239924A5070219180 @default.
- W2169239924 hasBestOaLocation W21692399241 @default.
- W2169239924 hasConcept C126322002 @default.
- W2169239924 hasConcept C134018914 @default.
- W2169239924 hasConcept C142724271 @default.
- W2169239924 hasConcept C170493617 @default.
- W2169239924 hasConcept C203014093 @default.
- W2169239924 hasConcept C204787440 @default.
- W2169239924 hasConcept C27016395 @default.
- W2169239924 hasConcept C27081682 @default.
- W2169239924 hasConcept C2778728240 @default.
- W2169239924 hasConcept C2778937273 @default.
- W2169239924 hasConcept C2779591629 @default.
- W2169239924 hasConcept C2779611605 @default.
- W2169239924 hasConcept C71924100 @default.
- W2169239924 hasConcept C84393581 @default.
- W2169239924 hasConcept C98274493 @default.
- W2169239924 hasConceptScore W2169239924C126322002 @default.
- W2169239924 hasConceptScore W2169239924C134018914 @default.
- W2169239924 hasConceptScore W2169239924C142724271 @default.
- W2169239924 hasConceptScore W2169239924C170493617 @default.
- W2169239924 hasConceptScore W2169239924C203014093 @default.
- W2169239924 hasConceptScore W2169239924C204787440 @default.
- W2169239924 hasConceptScore W2169239924C27016395 @default.
- W2169239924 hasConceptScore W2169239924C27081682 @default.
- W2169239924 hasConceptScore W2169239924C2778728240 @default.
- W2169239924 hasConceptScore W2169239924C2778937273 @default.
- W2169239924 hasConceptScore W2169239924C2779591629 @default.
- W2169239924 hasConceptScore W2169239924C2779611605 @default.
- W2169239924 hasConceptScore W2169239924C71924100 @default.
- W2169239924 hasConceptScore W2169239924C84393581 @default.
- W2169239924 hasConceptScore W2169239924C98274493 @default.
- W2169239924 hasIssue "803" @default.
- W2169239924 hasLocation W21692399241 @default.
- W2169239924 hasLocation W21692399242 @default.
- W2169239924 hasLocation W21692399243 @default.
- W2169239924 hasLocation W21692399244 @default.
- W2169239924 hasOpenAccess W2169239924 @default.
- W2169239924 hasPrimaryLocation W21692399241 @default.
- W2169239924 hasRelatedWork W1966732677 @default.
- W2169239924 hasRelatedWork W1968934283 @default.
- W2169239924 hasRelatedWork W1975864662 @default.
- W2169239924 hasRelatedWork W2011278726 @default.
- W2169239924 hasRelatedWork W2030365219 @default.
- W2169239924 hasRelatedWork W2094193054 @default.
- W2169239924 hasRelatedWork W2149729817 @default.
- W2169239924 hasRelatedWork W2169239924 @default.
- W2169239924 hasRelatedWork W2324052893 @default.
- W2169239924 hasRelatedWork W2995691456 @default.
- W2169239924 hasVolume "68" @default.
- W2169239924 isParatext "false" @default.
- W2169239924 isRetracted "false" @default.
- W2169239924 magId "2169239924" @default.
- W2169239924 workType "article" @default.